B-cell antigen receptor (BCR) specific for pneumococcal capsular polysaccharides (BCR)

B-cell antigen receptors (BCRs) specific for pneumococcal capsular polysaccharides are specialized membrane-bound immunoglobulins found on the surface of B lymphocytes. These receptors play a pivotal role in the immune system by recognizing and binding to the complex carbohydrate structures that form the protective capsules of 13 Streptococcus pneumoniae serotypes, including 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F (CDC, 2023; FDA, 2010). Upon antigen binding, the BCR triggers signal transduction pathways that lead to B-cell activation, clonal expansion, and differentiation into antibody-secreting plasma cells and memory B cells (Treanor, 2014). In the context of vaccination, these receptors are the primary targets for pneumococcal conjugate vaccines (PCVs), which utilize the polysaccharides linked to carrier proteins to induce a T-cell dependent immune response (Pollard et al., 2009). This interaction is essential for generating high-affinity IgG antibodies that opsonize the bacteria for phagocytosis, thereby preventing invasive diseases such as pneumonia, meningitis, and bacteremia (WHO, 2019). Monitoring the activity and frequency of these specific BCRs serves as a critical measure of vaccine efficacy and long-term immunological memory.

Other names

B-cell receptorSurface immunoglobulinsIgAntigen-specific B-cell receptorPneumococcal-specific BCRPCV13-specific B-cell receptor

Pneumococcal conjugate vaccines (PCVs) act by binding their polysaccharide antigens to the specific B-cell antigen receptors (BCRs) on naive B cells. The protein carrier (e.g., CRM197) is then internalized, processed, and presented to T-helper cells, which provide the necessary signals for the B cell to undergo isotype switching, affinity maturation, and differentiation into long-lived plasma cells and memory B cells (Pollard et al., 2009; FDA, 2010).